New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Top of the News-dtet
Generalizing Genomics Learning
A new NIH network aims to remove barriers and share knowledge to drive more widespread adoption of genomics in clinical settings
Lost Ground: Cancer Screening in the COVID-19 Era
A pandemic-related drop in cancer diagnoses could spell long-term trouble for patients and providers.
Exome Sequencing May Aid in Prenatal Diagnosis
From - Diagnostic Testing & Emerging Technologies
Clinical whole-exome sequencing (WES) has been utilized for both pediatric and adult patients with…
Genetic Test Ordering Management Programs Can Save Costs
From - Diagnostic Testing & Emerging Technologies
As use of clinical molecular testing skyrockets, many believe a closer examination of ordering patterns is warranted. Molecular tests have the potential to…
Re-considering PSA Screening Strategies to Catch Aggressive Cases
From - Diagnostic Testing & Emerging Technologies
The number of new cases of metastatic prostate cancer climbed 72 percent from 2004 to 2013, according to a controversial new study published…
Laboratory Review of Genetic Test Orders Cuts Errors, Costs
...
Already a member? Log in here
RNA Profiling May Aid in Fever Differentiation in Infants, Children
...
Already a member? Log in here
HIV Screening Underutilized, Particularly in Physicians’ Offices
...
Already a member? Log in here
Refined PSA Screening Strategies May Catch More Aggressive Cases
...
Already a member? Log in here
Incidental Pharmacogenomic Findings Can Help Personalize Treatment
From - Diagnostic Testing & Emerging Technologies
Clinically relevant pharmacogenomic findings are seen in single nucleotide polymorphism (SNP) genotyping and exome sequencing data…
Genotyping Reveals Relevant, Incidental Pharmacogenomic Findings
...
Already a member? Log in here